NIOX Group Plc (CSSPF)

USD 0.75

(0.0%)

Market Cap (In USD)

298.48 Million

Revenue (In USD)

46.84 Million

Net Income (In USD)

13.64 Million

Avg. Volume

19.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.75-0.76691
PE
-
EPS
-
Beta Value
0.938
ISIN
GB00BJVD3B28
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Ian Roy Johnson
Employee Count
-
Website
https://investors.niox.com
Ipo Date
2020-02-03
Details
NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.